Viscosupplementation uses hyaluronic acid injected into an affected joint as a treatment option for certain forms of osteoarthritis. Every viscosupplementation injection at TPL is performed by a qualified medical provider using ultrasound guidance for accurate intra-articular placement.
Viscosupplementation involves injecting hyaluronic acid into an affected joint. It may be considered as part of a physician-directed treatment plan for certain forms of osteoarthritis when clinically appropriate.
Viscosupplementation may be considered for certain patients experiencing pain, stiffness or functional limitations related to knee osteoarthritis.
Treatment of the hip, shoulder or ankle may be considered in selected cases based on clinical findings and the medical provider’s recommendation.
Treatment may be incorporated into a broader plan designed to address joint symptoms, movement and activity tolerance.
An evaluation can help determine whether viscosupplementation or another treatment option may be appropriate for your joint symptoms. Common conditions and concerns evaluated include:
Each patient is evaluated before treatment to confirm the diagnosis, review available options and determine whether viscosupplementation is clinically appropriate.
A medical provider reviews your symptoms, medical history, examination findings and relevant imaging.
The provider determines whether a single injection or a series of injections is appropriate based on the selected product and the patient’s individual needs.
The viscosupplement is injected into the targeted joint using ultrasound guidance for accurate intra-articular placement.
Each treatment includes a follow-up visit, which may be completed in person or through telehealth based on clinical need and patient preference. Activity recommendations and rehabilitation may also be coordinated as indicated.
Each treatment series includes a medical evaluation, the complete series of ultrasound-guided injections and a follow-up visit.
Response and duration vary based on the affected joint, the severity of the condition and the individual patient. A medical provider can discuss expected outcomes following evaluation.
The number of injections depends on the selected viscosupplementation product and the patient’s individual treatment plan. Some products involve a single injection, while others are administered as a series.
Patients may experience discomfort during the injection and temporary soreness afterward. Every injection is performed using ultrasound guidance, and the treatment team will provide individualized post-procedure instructions.
Coverage varies by insurance plan, affected joint and medical-necessity requirements. Our team can review available coverage and self-pay options before treatment.
